Fusion Pharmaceuticals In... (FUSN)
NASDAQ: FUSN
· Real-Time Price · USD
21.55
0.03 (0.14%)
At close: Jun 03, 2024, 10:00 PM
0.14% (1D)
| Bid | n/a |
| Market Cap | 1.83B |
| Revenue (ttm) | 35.68M |
| Net Income (ttm) | -104.28M |
| EPS (ttm) | -1.4 |
| PE Ratio (ttm) | -15.392857142857142 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 6,081,107 |
| Avg. Volume (20D) | 1,965,984 |
| Open | 21.55 |
| Previous Close | 21.52 |
| Day's Range | 21.48 - 21.58 |
| 52-Week Range | 2.31 - 21.60 |
| Beta | -0.69 |
About FUSN
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol FUSN
Website n/a
3 months ago · investopedia.com
AstraZeneca to Buy Fusion Pharmaceuticals for Up to $2.4B as Firm Expands Cancer PipelineAstraZeneca Plc (AZN) on Tuesday said it will acquire biotech company Fusion Pharmaceuticals Inc. (FUSN) for up to $2.4 billion, expanding its pipeline of treatment for advanced prostate cancer.